These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28073362)

  • 21. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women.
    Lamon-Fava S; Herrington DM; Reboussin DM; Sherman M; Horvath KV; Cupples LA; White C; Demissie S; Schaefer EJ; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):575-9. PubMed ID: 18174456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma pre beta1-HDL level is elevated in unstable angina pectoris.
    Tashiro J; Miyazaki O; Nakamura Y; Miyazaki A; Fukamachi I; Bujo H; Saito Y
    Atherosclerosis; 2009 Jun; 204(2):595-600. PubMed ID: 19054517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H; Isbir T; Agachan B; Karaali ZE
    Cell Biochem Funct; 2005; 23(1):23-8. PubMed ID: 15386541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
    Boekholdt SM; Kuivenhoven JA; Wareham NJ; Peters RJ; Jukema JW; Luben R; Bingham SA; Day NE; Kastelein JJ; Khaw KT
    Circulation; 2004 Sep; 110(11):1418-23. PubMed ID: 15337694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitavastatin decreases plasma prebeta1-HDL concentration and might promote its disappearance rate in hypercholesterolemic patients.
    Kawano M; Nagasaka S; Yagyu H; Ishibashi S
    J Atheroscler Thromb; 2008 Feb; 15(1):41-6. PubMed ID: 18270457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cholesteryl ester transfer protein concentrations are associated with serum levels of total cholesterol, beta-lipoprotein and apoproteins in patients with type 2 diabetes mellitus.
    Inukai Y; Ito K; Hara K; Yamazaki A; Takebayashi K; Aso Y; Inukai T
    Med Princ Pract; 2007; 16(5):367-72. PubMed ID: 17709925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined hepatic lipase -514C/T and cholesteryl ester transfer protein I405V polymorphisms are associated with the risk of coronary artery disease.
    Ghatrehsamani K; Darabi M; Rahbani M; Hashemzadeh Chaleshtory M; Farrokhi E; Noori M
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):809-15. PubMed ID: 19810818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia.
    Hassanzadeh T; Firoozrai M; Zonouz AE; Zavarehee A; Paoli M
    Indian J Med Res; 2009 Mar; 129(3):293-8. PubMed ID: 19491422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
    Kuivenhoven JA; Jukema JW; Zwinderman AH; de Knijff P; McPherson R; Bruschke AV; Lie KI; Kastelein JJ
    N Engl J Med; 1998 Jan; 338(2):86-93. PubMed ID: 9420339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness.
    Orem C; Durmuş I; Kilinç K; Baykan M; Gökçe M; Orem A; Topbaş M
    Coron Artery Dis; 2003 May; 14(3):219-24. PubMed ID: 12702925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
    Chaaba R; Hammami S; Attia N; Smaoui M; Masmoudi AS; Mahjoub S; Ben Hamda K; Hammami M
    Clin Biochem; 2005 Apr; 38(4):373-8. PubMed ID: 15766738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prebeta1-HDL is elevated in the fasting state, but markedly reduced postprandially in poorly controlled type 2 diabetic patients.
    Hirayama S; Ito T; Miyazaki O; Kamimura T; Hanyu O; Seino U; Ito S; Aizawa Y; Miida T
    Clin Chim Acta; 2009 Mar; 401(1-2):57-62. PubMed ID: 19056371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
    Seiler S; Schlitt A; Jiang XC; Ulrich C; Blankenberg S; Lackner KJ; Girndt M; Werdan K; Buerke M; Fliser D; Heine GH
    Nephrol Dial Transplant; 2008 Nov; 23(11):3599-604. PubMed ID: 18503096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
    Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein.
    Miyazaki O; Fukamachi I; Mori A; Hashimoto H; Kawashiri MA; Nohara A; Noguchi T; Inazu A; Yamagishi M; Mabuchi H; Kobayashi J
    Biochem Biophys Res Commun; 2009 Jan; 379(1):55-9. PubMed ID: 19070596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation).
    Nicholls SJ; Tuzcu EM; Brennan DM; Tardif JC; Nissen SE
    Circulation; 2008 Dec; 118(24):2506-14. PubMed ID: 19029466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a) complexes with beta2-glycoprotein I in patients with coronary artery disease.
    Wang JJ; Gong JB; Li HQ; Niu DM; Han AZ; Wu J; Zhang CN
    J Atheroscler Thromb; 2012; 19(1):81-9. PubMed ID: 22056596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Suzuki S; Gejyo F; Yoshida H
    Kidney Int; 2003 Nov; 64(5):1829-37. PubMed ID: 14531818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between cholesteryl ester transfer protein gene -629C→A mutations with HDL-C levels and coronary heart disease].
    Gao J; Mao YM; Cong HL; Liu Y; Zhang N; Chen Q; Liu T; Cui RZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):399-405. PubMed ID: 24021123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population.
    Wang J; Wang LJ; Zhong Y; Gu P; Shao JQ; Jiang SS; Gong JB
    Lipids Health Dis; 2013 Nov; 12():176. PubMed ID: 24283500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.